Nucleocapsid and matrix protein contributions to selective human immunodeficiency virus type 1 genomic RNA packaging

Journal of Virology

Volumn 72, Issue 3, 1998, Pages 1983-1993

  Poon, Dexter T K ^a   Li, Guangde ^a   Aldovini, Anna ^a,b  

^a HARVARD MEDICAL SCHOOL   (United States)

^b BOSTON CHILDREN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID COMPOSITION; AMINO ACID SEQUENCE; ARTICLE; GENE DELETION; GENOME; HUMAN IMMUNODEFICIENCY VIRUS 1; MOUSE MAMMARY TUMOR ONCOVIRUS; PRIORITY JOURNAL; PROTEIN ANALYSIS; RNA ANALYSIS; RNA BINDING; VIRUS NUCLEOCAPSID;

EID: 0031888826     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.72.3.1983-1993.1998     Document Type: Article

References (52)

1. Aldovini, A., and R. A. Young. 1990. Mutations of RNA and protein sequences involved in human immunodeficiency virus type 1 packaging result in production of noninfectious virus. J. Virol. 64:1920-1926.
2. Aldovini, A, and M. B. Feinberg. 1990. Transfection of molecularly cloned HIV genomes, p. 147-175. In A. Aldovini and B. D. Walker (ed.), Techniques in HIV research. Stockton Press, Inc., New York, N.Y.
3. Aldovini, A., and R. A. Young. 1994. Construction and analysis of HIV and SIV mutants. Methods Mol. Genet. 4A:3-17.
4. Ausubel, F. M., R. Brent, R. E. Kingston, D. D. Moore, J. G. Seidman, J. A. Smith, and K. Struhl (ed.). 1987. Current protocols in molecular biology. John Wiley and Sons, Inc., New York, N.Y.
5. Bennet, R. P., T. D. Nelle, and J. W. Willis. 1993. Functional chimeras of the Rous sarcoma virus and human immunodeficiency virus Gag proteins. J. Virol. 67:6487-6498.
6. Berg, J. 1986. Potential metal-binding domains in nucleic acid binding proteins. Science 232:485-486.
7. Berkowitz, R. D., A. Ohagen, S. Hoglund, and S. P. Goff. 1995. Retroviral nucleocapsid domains mediate the specific recognition of genomic viral RNAs by chimeric polyproteins during RNA packaging in vivo. J. Virol. 69:6445-6456.
8. Bowles, N. E., P. Damay, and P. F. Spahr. 1993. Effect of rearrangements and duplications of the Cys-His motifs of Rous sarcoma virus nucleocapsid protein. J. Virol. 67:623-631.
9. Campbell, S., and V. M. Vogt. 1995. Assembly in vitro of purified CA-NC proteins from Rous sarcoma virus and human immunodeficiency virus type 1. J. Virol. 69:6487-6497.
10. Daniel, M. D., N. L. Letvin, N. W. King, P. M. Kannagi, P. K. Sehgal, R. D. Hunt, P. J. Kanki, M. Essex, and R. C. Desrosiers. 1985. Isolation of a T cell tropic HTLV-III-like retrovirus from macaques. Science 228:1201-1204.
11. Darlix, J. L., and P. F. Spahr. 1982. Binding sites of viral protein p19 onto Rous sarcoma virus RNA and possible controls of viral function. J. Mol. Biol. 160:147-161.
12. Darlix, J. L., M. Lapadat-Tapolski, H. De Rocquigny, and B. P. Roques. 1995. First glimpses at structure function relationships of the nucleocapsid protein of retroviruses. J. Mol. Biol. 254:523-537.
13. Dupraz, P., and P. F. Spahr. 1992. Specificity of Rous sarcoma virus nucleocapsid protein in genomic RNA packaging. J. Virol. 66:4662-4670.
14. Embretson, J. E., and H. M. Temin. 1987. Lack of competition results in efficient packaging of heterologous murine retroviral RNAs and reticuloendotheliosis virus encapsidation-minus RNAs by the reticuloendotheliosis virus helper cell line. J. Virol. 61:2675-2683.
15. Fäcke, M., A. Janetzko, R. L. Shoeman, and H.-G. Kräusslich. 1993. A large deletion in the matrix domain of the human immunodeficiency virus gag gene redirects virus particle assembly from the plasma membrane to the endoplasmic reticulum. J. Virol. 67:4972-4980.
16. Feinberg, M. B., R. F. Jarrett, A. Aldovini, R. C. Gallo, and F. Wong-Staal. 1986. HTLV-III expression and production involve complex regulation at the levels of splicing and translation of viral RNA. Cell 46:807-817.
17. Fisher, A. G., E. Collalti, E. Ratner, R. C. Gallo, and F. Wong-Staal. 1985. A molecular clone of HTLV-III with biological activity. Nature 316:262-265.
18. Franke, E. K., H. E. H. Yuan, K. L. Bossolt, S. P. Goff, and J. Luban. 1994. Specificity and sequence requirements for interactions between various retroviral Gag proteins. J. Virol. 68:5300-5305.
19. Gheysen, D., E. Jacobs, F. de Foresta, C. Thiriat, M. Francotte, D. Thines, and M. DeWilde. 1989. Assembly and release of HIV-1 precursor Pr55gag virus like particles from recombinant baculovirus-infected insect cells. Cell 59:103-112.
20. Gorelick, R. J., D. J. Chabot, A. Rein, L. E. Henderson, and L. O. Arthur. 1993. The two zinc fingers in the human immunodeficiency virus type 1 ucleocapsid protein are not functionally equivalent. J. Virol. 67:4027-4036.
21. Gorelick, R. J., D. J. Chabot, D. E. Ott, T. D. Gagliardi, A. Rein, L. E. Henderson, and L. O. Arthur. 1996. Genetic analysis of the zinc finger in the Moloney murine leukemia virus nucleocapsid domain: replacement of zinc-coordinating residues with other zinc-coordinating residues yields noninfectious particles containing genomic RNA. J. Virol. 70:2593-2597.
22. Horton, R. M., S. N. Ho, J. K. Pullen, H. D. Hunt, Z. Cai, and L. R. Pease. 1993. Gene splicing by overlap extension. Methods Enzymol. 217H:270-279.
23. Jowett, J. B., D. J. Hockley, M. V. Nermut, and I. M. Jones. 1992. Distinct signals in human immunodeficiency virus type 1 Pr55 necessary for RNA binding and particle formation. J. Gen. Virol. 73:3079-3086.
24. Kain, S. R., T. I. Jen, and G. L. Firestone. 1993. Glucocorticoid regulated trafficking of mouse mammary tumor virus proteins in permeabilized hepatoma cells. J. Biol. Chem. 268:19640-19649.
25. Karpel, R. L., L. E. Henderson, and S. Orolszlan. 1987. Interactions of retroviral structural proteins with single-stranded nucleic acids. J. Biol. Chem. 262:4961-4967.
26. Katoh, I., H. Kyushiki, Y. Sakamoto, Y. Ikawa, and Y. Yoshinaka. 1991. Bovine leukemia virus matrix-associated protein MA(p15): further processing and formation of a specific complex with the dimer of the 5′-terminal genomic RNA fragment. J. Virol. 65:6845-6855.
27. Kojima, E., T. Shirasaka, B. D. Andersen, S. Chokekijchai, S. M. Steinberg, S. Broder, R. Yarchoan, and H. Mitsuya. 1995. Human immunodeficiency virus type 1 (HIV-1) viremia changes and development of drug-related mutations in patients with symptomatic HIV-1 infections receiving alternating or simultaneous zidovudine and didanosine therapy. J. Infect. Dis. 171: 1152-1158.
28. Laemmli, U. K. 1970. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227:680-685.
29. Lapadat-Tapolsky, M., H. De Rocquigny, D. Van Gent, B. Roques, R. Plasterk, and J. L. Darlix. 1993. Interactions between HIV-1 nucleocapsid protein and viral DNA may have important functions in the viral life cycle. Nucleic Acids Res. 21:831-839.
30. Lee, P. P., and M. L. Linial. 1994. Efficient particle formation can occur if the matrix domain of human immunodeficiency virus type 1 Gag is substituted by a myristylation signal. J. Virol. 68:6644-6654.
31. + T lymphocytes. J. Virol. 71:1443-1452.
32. Leis, J. P., J. McGinnis, and R. W. Green. 1978. Rous sarcoma virus p19 binds to specific double stranded regions of viral RNA: effect of p19 on cleavage of viral RNA by RNase III. Virology 84:87-98.
33. Leis, J. P., P. Scheible, and R. E. Smith. 1980. Correlation of RNA binding affinity of avian oncornavirus p19 proteins with the extent of processing of virus genome RNA in cells. J. Virol. 35:722-731.
34. Luban, J., and S. P. Goff. 1991. Binding of human immunodeficiency virus type 1 (HIV-1) RNA to recombinant HIV-1 Gag polyprotein. J. Virol. 65:3203-3212.
35. Maurer, B., H. Bannaret, G. Darai, and R. M. Flugel. 1988, Analysis of the primary structure of the long terminal repeat and the gag and pol genes of the human spumaretrovirus. J. Virol. 62:1590-1597.
36. Meric, C., and P. F. Spahr. 1986. Rous sarcoma virus nucleic acid-binding protein p12 is necessary for viral 70S RNA dimer formation and packaging. J. Virol. 60:450-459.
37. Meric, C., E. Gouilloud, and P.-F. Spahr. 1988. Mutations in Rous sarcoma virus nucleocapsid protein p12(NC): deletions of Cys-His boxes. J. Virol. 62:3328-3333.
38. Méric, C., and S. P. Goff. 1989. Characterization of Moloney murine leukemia virus mutants with single-amino-acid substitutions in the Cys-His box of the nucleocapsid protein. J. Virol. 63:1558-1568.
39. Moore, R., M. Dixon, R. Smith, G. Peters, and C. Dickson. 1987. Complete nucleotide sequence of a milk-transmitted mouse mammary tumor virus: two frameshift suppression events are required for translation of gag and pol. J. Virol. 61:480-490.
40. Poon, D. T. K., J. Wu, and A. Aldovini. 1996. Charged amino acid residues of human immunodeficiency virus type 1 nucleocapsid p7 protein involved in RNA packaging and infectivity. J. Virol. 70:6607-6616.
41. Popovic, M., M. G. Sarngadbaran, E. Read, and R. C. Gallo. 1984. Detection isolation, and continuous production of cytopathic retroviruses (HTLV-III) from patients with AIDS and pre-AIDS. Science 224:497-500.
42. Ratner, L., W. Haseltine, R. Patarca, K. J. Livak, B. Starcich, S. F. Josephs, E. R. Doran, J. A. Rafalski, E. A. Whitehorn, K. Baumeister, L. Ivanoff, S. R. Petteway, Jr., M. L. Pearson, J. A. Lautenberg, T. S. Papas, J. Ghrayeb, N. T. Chang, R. C. Gallo, and F. Wong-Staal. 1985. Complete nucleotide sequence of the AIDS virus, HTLV-III. Nature 313:277-284.
43. Rein, A. 1994. Retroviral RNA packaging: a review. Arch. Virol. Suppl. 9:513-522.
44. Riviere, I., K. Brose, and R. C. Mulligan. 1995. Effects of retroviral vector design on expression of human adenosine deaminase in murine bone marrow transplant recipients engrafted with genetically modified cells. Proc. Natl. Acad. Sci. USA 92:6733-6737.
45. Schmalzbauer, E., B. Strack, J. Dannull, S. Guehmann, and K. Moelling. 1996. Mutations of basic amino acids of NCp7 of human immunodeficiency virus type 1 affect RNA binding in vitro. J. Virol. 70:771-777.
46. Sen, A., and G. Todaro. 1977. The genome associated, specific RNA binding proteins of avian and mammalian type C viruses. Cell 10:91-99.
47. Shackleford, G. M., and H. E. Varmus. 1988. Construction of a clonable, infectious, and tumorigenic mouse mammary tumor virus provirus and a derivative genetic vector. Proc. Natl. Acad. Sci. USA 85:9655-9659.
48. Shinnick, T. M., R. A. Lerner, and J. G. Sutclife. 1981. Nucleotide sequence of Moloney murine leukaemia virus. Nature 293:543-548.
49. gag) of avian sarcoma and leukemia viruses. J. Virol. 64:847-855.
50. Travers, K., and P. J. Kanki. 1990. HIV antibody detection in serum, p. 3-14. In A. Aldovini and B. D. Walker (ed.), Techniques in HIV research. Stockton Press, Inc., New York, N.Y.
51. Tsomides, T. J., A. Aldovini, R. P. Johnson, B. D. Walker, R. A. Young, and H. N. Eisen. 1994. Naturally processed viral peptides recognized by cytotoxic T lymphocytes on cells chronically infected by human immunodeficiency virus type 1 (HIV-1). J. Exp. Med. 180:1283-1293.
52. Zhang, Y., and E. Barklis. 1995. Nucleocapsid protein effects on the specificity of retrovirus RNA encapsidation. J. Virol. 69:5716-5722.